An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Conditions

• Major Depressive Disorder

Interventions

• DRUG: Lumateperone

Sponsor

Intra-Cellular Therapies, Inc.